BibTex RIS Cite

Prognostic value of vestibular evoked myogenic potential and distortion product otoacoustic emission tests in patients with a diagnosis of sudden hearing loss: A preliminary report

Year 2020, Volume: 30 Issue: 4, 147 - 157, 15.12.2020

Abstract

Objectives: This study aims to investigate whether vestibular evoked myogenic potentials VEMPs and distortion product otoacoustic emissions DPOAEs have prognostic values in the follow-up of patients diagnosed with idiopathic sudden sensorineural hearing loss ISSNHL with audiological tests. Patients and Methods: Between June 2013 and January 2014, a total of 27 patients 11 males, 16 females; mean age: 44.9±13.8 years; range, 18 to 60 years diagnosed with ISSNHL at their first admissions and underwent VEMP and DPOAE tests were included. As the treatment protocol, steroid treatment combined with hyperbaric oxygen therapy was initiated in all patients. At the second month of the treatment, all patients underwent VEMP and DPOAE tests once again. Hearing recovery was evaluated based on the hearing improvement, compared to the unaffected contralateral ear. Results: The median recovery rate was statistically significantly higher in the patients with normal pre-treatment VEMP test results than those with abnormal VEMP test results p=0.023 . The median recovery rate was statistically significantly higher in the patients with normal post-treatment VEMP test results compared to those with abnormal post-treatment VEMP test results p=0.031 . The median recovery rate was also statistically significantly higher in the post-treatment DPOAE test positivity than the post-treatment DPOAE test negativity p<0.001 . Conclusion: Our study results suggest that, in the follow-up of the prognosis of ISSNHL disease, VEMP test may have a prognostic value, while DPOAE test is an important parameter which can be used in the monitorization of the disease.

References

  • Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-80.
  • Byl FM. Seventy-six cases of presumed sudden hearing loss occurring in 1973: Prognosis and incidence. Laryngoscope 1977;87:817-25.
  • Yoshida Y, Yamauchi S, Shinkawa A, Horiuchi M, Sakai M. Immunological and virological study of sudden deafness. Auris Nasus Larynx 1996;23:63-8.
  • Lazarini PR, Camargo AC. Idiopathic sudden sensorineural hearing loss: etiopathogenic aspects. Braz J Otorhinolaryngol 2006;72:554-61.
  • Nomura Y, Hiraide F. Sudden deafness. A histopathological study. J Laryngol Otol 1976;90:1121-42.
  • Shikowitz MJ. Sudden sensorineural hearing loss. Med Clin North Am 1991;75:1239-50.
  • Jaffe BF. Hypercoagulation and other causes of sudden hearing loss. Otolaryngol Clin North Am 1975;8:395-403.
  • Liao BS, Byl FM, Adour KK. Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence for viral cause. Otolaryngol Head Neck Surg 1992;106:226-9.
  • Pereira DT, Vendramini RC, David RB, Nozaki PN, Menani JV, De Luca LA Jr. Isotonic NaCl intake by cell- dehydrated rats. Physiol Behav 2002;76:501-5.
  • Nomura Y. Perilymph fistula: concept, diagnosis and management. Acta Otolaryngol Suppl 1994;514:52-4.
  • Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 1984;94:664-6.
  • Lamm K, Lamm H, Arnold W. Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus. A literature survey. Adv Otorhinolaryngol 1998;54:86-99.
  • Rowson KE, Hinchcliffe R. A virological and epidemiological study of patients with acute hearing loss. Lancet 1975;1:471-3.
  • Colebatch JG, Halmagyi GM. Vestibular evoked potentials in human neck muscles before and after unilateral vestibular deafferentation. Neurology 1992;42:1635-6.
  • Colebatch JG, Halmagyi GM, Skuse NF. Myogenic potentials generated by a click-evoked vestibulocollic reflex. J Neurol Neurosurg Psychiatry 1994;57:190-7.
  • Franklin DJ, McCoy MJ, Martin GK, Lonsbury-Martin BL. Test/retest reliability of distortion-product and transiently evoked otoacoustic emissions. Ear Hear 1992;13:417-29.
  • Hotz MA, Harris FP, Probst R. Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity. Laryngoscope 1994;104:1130-4.
  • Murofushi T. Vestibular evoked myogenic potential. Otolaryngol Head Neck Surg (Tokyo) 2003;75:165-9.
  • Wang CT, Huang TW, Kuo SW, Cheng PW. Correlation between audiovestibular function tests and hearing outcomes in severe to profound sudden sensorineural hearing loss. Ear Hear 2009;30:110-4.
  • Mori T, Suzuki H, Hiraki N, Hashida K, Ohbuchi T, Katoh A, et al. Prediction of hearing outcomes by distortion product otoacoustic emissions in patients with idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2011;38:564-9.
  • Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980;106:772-6.
  • Snow JB, Telian SA. Sudden deafness. In: Paparella MM Shumrick DA, editors. Otolaryngology. Vol 2, 3rd ed. Philadelphia: W.B. Saunders;1992. p. 1619-28.
  • Stokroos RJ, Albers FW, Schirm J. Therapy of idiopathic sudden sensorineural hearing loss: antiviral treatment of experimental herpes simplex virus infection of the inner ear. Ann Otol Rhinol Laryngol 1999;108:423-8.
  • Booth JB. Sudden and fluctuant sensorineural hearingloss. In: Kerr AG, editor. Scott Brown’s Otolaryngology. 6th ed. London: Butterworths- Heinemann; 1997. p. 1-82.
  • Wilson WR, Gulya AJ. Sudden sensorineural hearing loss. In: Cummings CW, Frederirickson JM, Harker LA, Krause CJ, Schuller DE, editors. Otolaryngology- Head and Neck Surgery. St Louis: Mosby; 1993. p. 3103- 112.
  • Samim E, Kilic R, Ozdek A, Gocmen H, Eryilmaz A, Unlu I. Combined treatment of sudden sensorineural hearing loss with steroid, dextran and piracetam: experience with 68 cases. Eur Arch Otorhinolaryngol 2004;261:187-90.
  • Sano H, Shitara T, Okamoto M, Hirayama M. Investigation of pure-tone hearing levels at a single frequency in sudden deafness. Acta Otolaryngol Suppl 1994;514:21-6.
  • Saeki N, Kitahara M. Assessment of prognosis in sudden deafness. Acta Otolaryngol Suppl 1994;510:56-61.
  • Park HM, Jung SW, Rhee CK. Vestibular diagnosis as prognostic indicator in sudden hearing loss with vertigo. Acta Otolaryngol Suppl 2001;545:80-3.
  • Sheehy JL. Vasodilator therapy in sensory-neural hearing loss. Laryngoscope 1960;70:885-914.
  • Morizono T, Paparella MM. Hypercholesterolemia and auditory dysfunction. Experimental studies. Ann Otol Rhinol Laryngol 1978;87:804-14.
  • Wilke H, Grossgerge H, Haubold E, Kahlke W, Frahm H, Regler B. Frequency and distribution of risk factors in hearing loss. Fortschr Med 1977;95:1757-64.
  • Wilson WR, Veltri RW, Laird N, Sprinkle PM. Viral and epidemiologic studies of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 1983;91:653-8.
  • Welgampola MS, Colebatch JG. Characteristics of tone burst-evoked myogenic potentials in the sternocleidomastoid muscles. Otol Neurotol 2001;22:796-802.
  • Rauch SD, Zhou G, Kujawa SG, Guinan JJ, Herrmann BS. Vestibular evoked myogenic potentials show altered tuning in patients with Ménière’s disease. Otol Neurotol 2004;25:333-8.
  • Petrak MR. Vestibular Evoked Myogenic Potential (VEMP) - Clinical Applications, Product Manager - Balance Assessment, GN Otometrics, Chicago, IL USA, III. Ulusal Odyoloji Kongresi Prezentasyonları, 14-16 Eylül 2006, Ankara.
  • Wang CT, Huang TW, Kuo SW, Cheng PW. Correlation between audiovestibular function tests and hearing outcomes in severe to profound sudden sensorineural hearing loss. Ear Hear 2009;30:110-4.
  • Iwasaki S, Takai Y, Ozeki H, Ito K, Karino S, Murofushi T. Extent of lesions in idiopathic sudden hearing loss with vertigo: Study using click and galvanic vestibular evoked myogenic potentials. Arch Otolaryngol Head Neck Surg 2005;131:857-62.
  • Rajati M, Bakhshaee M, Naghavi E, Hoseinnejad F, Rouhi HR, Movahhed R. Studying VEMP in sudden sensorineural hearing loss. Iran J Otorhinolaryngol 2011;23:64.
  • Hong SM, Byun JY, Park CH, Lee JH, Park MS, Cha CI. Saccular damage in patients with idiopathic sudden sensorineural hearing loss without vertigo. Otolaryngol Head Neck Surg 2008;139:541-5.
  • Stamatiou G, Gkoritsa E, Xenellis J, Riga M, Korres S. Semicircular canal versus otolithic involvement in idiopathic sudden hearing loss. J Laryngol Otol 2009;123:1325-30.
  • Chao TK, Chen TH. Distortion product otoacoustic emissions as a prognostic factor for idiopathic sudden sensorineural hearing loss. Audiol Neurootol 2006;11:331-8.
There are 42 citations in total.

Details

Primary Language English
Journal Section Research Article
Authors

Bekir Bilgi This is me

Mustafa Deniz Yılmaz This is me

Hülya Erigör This is me

Ömer Tarık Selçuk This is me

Üstün Osma This is me

Levent Renda This is me

Ünal Gökalp Işık This is me

Publication Date December 15, 2020
Published in Issue Year 2020 Volume: 30 Issue: 4

Cite

APA Bilgi, B., Yılmaz, M. D., Erigör, H., Selçuk, Ö. T., et al. (2020). Prognostic value of vestibular evoked myogenic potential and distortion product otoacoustic emission tests in patients with a diagnosis of sudden hearing loss: A preliminary report. The Turkish Journal of Ear Nose and Throat, 30(4), 147-157.
AMA Bilgi B, Yılmaz MD, Erigör H, Selçuk ÖT, Osma Ü, Renda L, Işık ÜG. Prognostic value of vestibular evoked myogenic potential and distortion product otoacoustic emission tests in patients with a diagnosis of sudden hearing loss: A preliminary report. Tr-ENT. December 2020;30(4):147-157.
Chicago Bilgi, Bekir, Mustafa Deniz Yılmaz, Hülya Erigör, Ömer Tarık Selçuk, Üstün Osma, Levent Renda, and Ünal Gökalp Işık. “Prognostic Value of Vestibular Evoked Myogenic Potential and Distortion Product Otoacoustic Emission Tests in Patients With a Diagnosis of Sudden Hearing Loss: A Preliminary Report”. The Turkish Journal of Ear Nose and Throat 30, no. 4 (December 2020): 147-57.
EndNote Bilgi B, Yılmaz MD, Erigör H, Selçuk ÖT, Osma Ü, Renda L, Işık ÜG (December 1, 2020) Prognostic value of vestibular evoked myogenic potential and distortion product otoacoustic emission tests in patients with a diagnosis of sudden hearing loss: A preliminary report. The Turkish Journal of Ear Nose and Throat 30 4 147–157.
IEEE B. Bilgi, “Prognostic value of vestibular evoked myogenic potential and distortion product otoacoustic emission tests in patients with a diagnosis of sudden hearing loss: A preliminary report”, Tr-ENT, vol. 30, no. 4, pp. 147–157, 2020.
ISNAD Bilgi, Bekir et al. “Prognostic Value of Vestibular Evoked Myogenic Potential and Distortion Product Otoacoustic Emission Tests in Patients With a Diagnosis of Sudden Hearing Loss: A Preliminary Report”. The Turkish Journal of Ear Nose and Throat 30/4 (December 2020), 147-157.
JAMA Bilgi B, Yılmaz MD, Erigör H, Selçuk ÖT, Osma Ü, Renda L, Işık ÜG. Prognostic value of vestibular evoked myogenic potential and distortion product otoacoustic emission tests in patients with a diagnosis of sudden hearing loss: A preliminary report. Tr-ENT. 2020;30:147–157.
MLA Bilgi, Bekir et al. “Prognostic Value of Vestibular Evoked Myogenic Potential and Distortion Product Otoacoustic Emission Tests in Patients With a Diagnosis of Sudden Hearing Loss: A Preliminary Report”. The Turkish Journal of Ear Nose and Throat, vol. 30, no. 4, 2020, pp. 147-5.
Vancouver Bilgi B, Yılmaz MD, Erigör H, Selçuk ÖT, Osma Ü, Renda L, Işık ÜG. Prognostic value of vestibular evoked myogenic potential and distortion product otoacoustic emission tests in patients with a diagnosis of sudden hearing loss: A preliminary report. Tr-ENT. 2020;30(4):147-5.